Hadasit Bio (HDST) — Long-term Investment Intensity

Latest as of June 2019: 67.9%

Hadasit Bio (HDST) has a Long-term Investment Intensity of 67.9% as of June 2019. Long-term investments of ILA12.04 Million represent 67.9% of total assets of ILA17.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Hadasit Bio book value and equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

67.9%
LT Investments / Total Assets

Long-term Investments

ILA12.04 Million
ILA

Total Assets

ILA17.73 Million
ILA

Country

Israel
TA

Hadasit Bio Long-term Investment Intensity (2013–2018)

This chart shows how Hadasit Bio's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 67.9%, reflecting long-term investments of ILA12.04 Million against total assets of ILA17.73 Million ILA. Also explore HDST total asset value for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Hadasit Bio (2013–2018)

The table below presents the year-by-year Long-term Investment Intensity for Hadasit Bio from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see HDST market cap.

Year LT Investment Intensity LT Investments (ILA) Total Assets Change (pp)
2018 48.0% ILA16.97 Million ILA35.34 Million ▲ +34.1 pp
2017 13.9% ILA9.53 Million ILA68.60 Million ▼ -5.1 pp
2016 19.0% ILA13.21 Million ILA69.46 Million ▲ +15.3 pp
2015 3.7% ILA2.54 Million ILA68.61 Million ▼ -10.4 pp
2014 14.2% ILA4.59 Million ILA32.42 Million ▼ -11.9 pp
2013 26.0% ILA9.05 Million ILA34.76 Million
pp = percentage points